Saltar al contenido
Merck

A case of erythema multiforme developing after levetiracetam therapy.

Dermatology online journal (2013-03-12)
Yavuz Yesilova, Enver Turan, Abdurahman Sonmez, Ilyas Ozardali
RESUMEN

Erythema multiforme is a skin disease, which occurs particularly in the acral region, and is characterized by target-like erythematous macules and papules. Infections play an important role in the etiology of erythema multiforme. Other causes include drugs, vaccination, and hematological malignancies. Half of all cases may not have an identifiable etiology. This article presents a male patient who developed erythema multiforme as a result of levetiracetam use for epilepsy.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Piracetam
Sigma-Aldrich
Levetiracetam, ≥98% (HPLC)
Supelco
Levetiracetam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Levetiracetam, European Pharmacopoeia (EP) Reference Standard
Levetiracetam impurity D, European Pharmacopoeia (EP) Reference Standard